Near‐infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase
- 5 August 2022
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 36 (9) , e22490
Abstract
There is solid evidence of the beneficial effect of photobiomodulation (PBM) with low‐power near‐infrared (NIR) light in the NIR‐I window in increasing bioavailable nitric oxide (NO). However, it is not established whether this effect can be extended to NIR‐II light, limiting broader applications of this therapeutic modality. Since we have demonstrated PBM with NIR laser in the NIR‐II window, we determined the causal relationship between NIR‐II irradiation and its specific biological effects on NO bioavailability. We analyzed the impact of NIR‐II irradiation on NO release in cultured human endothelial cells using a NO‐sensitive fluorescence probe and single‐cell live imaging. Two distinct wavelengths of NIR‐II laser (1064 and 1270 nm) and NIR‐I (808 nm) at an irradiance of 10 mW/cm 2 induced NO release from endothelial cells. These lasers also enhanced Akt phosphorylation at Ser 473, endothelial nitric oxide synthase (eNOS) phosphorylation at Ser 1177, and endothelial cell migration. Moreover, the NO release and phosphorylation of eNOS were abolished by inhibiting mitochondrial respiration, suggesting that Akt activation caused by NIR‐II laser exposure involves mitochondrial retrograde signaling. Other inhibitors that inhibit known Akt activation pathways, including a specific inhibitor of PI3K, Src family PKC, did not affect this response. These two wavelengths of NIR‐II laser induced no appreciable NO generation in cultured neuronal cells expressing neuronal NOS (nNOS). In short, NIR‐II laser enhances bioavailable NO in endothelial cells. Since a hallmark of endothelial dysfunction is suppressed eNOS with concomitant NO deficiency, NIR‐II laser technology could be broadly used to restore endothelial NO and treat or prevent cardiovascular diseases.Keywords
Funding Information
- Division of Intramural Research (R21AI144103)
- Deutsche Forschungsgemeinschaft (335549539‐GRK2381)
- National Institute of Neurological Disorders and Stroke (R01NS096237)
- Massachusetts General Hospital (Executive Committee On Research (ECOR) Interim Support Funding)
This publication has 74 references indexed in Scilit:
- The Chemical Interplay between Nitric Oxide and Mitochondrial CytochromecOxidase: Reactions, Effectors and PathophysiologyInternational Journal of Cell Biology, 2012
- Biphasic Dose Response in Low Level Light Therapy – an UpdateDose-Response, 2011
- Low intensity light stimulates nitrite-dependent nitric oxide synthesis but not oxygen consumption by cytochrome c oxidase: Implications for phototherapyJournal of Photochemistry and Photobiology B: Biology, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Characterization of Erythrocytic Uptake and Release and Disposition Pathways of Nitrite, Nitrate, Methemoglobin, and Iron-Nitrosyl Hemoglobin in the Human CirculationDrug Metabolism and Disposition, 2010
- Biphasic Dose Response in Low Level Light TherapyDose-Response, 2009
- Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanismJournal of Molecular and Cellular Cardiology, 2009
- Mitochondrial Signaling in Mammalian Cells Activated by Red and Near‐IR RadiationPhotochemistry and Photobiology, 2008
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Nitric Oxide and Cytochrome c Oxidase: Mechanisms of Inhibition and NO DegradationBiochemical and Biophysical Research Communications, 2000